Overview of Clinical Trial Study 1 (NCT03574597) was a multi-national, multi-center, placebo-controlled, double-blind trial to determine the effect of WEGOVY relative to placebo on major adverse cardiovascular events (MACE) when added to current standard of care, which included management of CV risk factors and individualized healthy lifestyle counseling (including diet and physical activity)
Accessible Communication: Expect a healthcare environment where your questions are welcomed
Pay Attention to Your Bodys Response Everyone reacts differently
Before starting the medication, clients will have a consultation to discuss options, check eligibility and receive a personalized plan
Then, take your Wegovy pen out of the refrigerator and look at the medicine through the window on the pen
Yes, common side effects like nausea, fatigue, or GI discomfort might reduce interest in sex temporarily, especially during dose escalation